-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Assets, Current history and growth rate from Q1 2022 to Q1 2025.
- LakeShore Biopharma Co., Ltd. Assets, Current for the quarter ending March 31, 2025 was ¥842M, a 6.75% decline year-over-year.
Assets, Current, Quarterly (CNY)
Assets, Current, YoY Quarterly Growth (%)